July 18, 2025 · Form 4 insider transaction
Lyon Joseph Douglas bought 200 shares of Corcept Therapeutics Incorporated at $13.56 per share, a transaction worth $2.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Includes 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.